AU2003280389A1 - O/W emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use thereof - Google Patents

O/W emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use thereof Download PDF

Info

Publication number
AU2003280389A1
AU2003280389A1 AU2003280389A AU2003280389A AU2003280389A1 AU 2003280389 A1 AU2003280389 A1 AU 2003280389A1 AU 2003280389 A AU2003280389 A AU 2003280389A AU 2003280389 A AU2003280389 A AU 2003280389A AU 2003280389 A1 AU2003280389 A1 AU 2003280389A1
Authority
AU
Australia
Prior art keywords
composition
peg
several
present
surfactants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003280389A
Inventor
Rolf Beutler
Martina Heberer
Valentina Paspaleevakuhn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merz Pharma GmbH and Co KGaA
Original Assignee
Merz Pharma GmbH and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma GmbH and Co KGaA filed Critical Merz Pharma GmbH and Co KGaA
Publication of AU2003280389A1 publication Critical patent/AU2003280389A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

The invention relates to a composition, in particular that may be foamed, with improved skin effect, based on an O/W emulsion with a combination of a silicone-based emulsifier and, in particular, an ionic surfactant. Stable emulsions can be formed with such a composition, which, on application, can be either dispersed or effectively foamed, with or without a propellant gas, which can then be easily applied to the skin and which there generates a particularly fine dispersion of the composition in the form of an emulsion, for example as a foam and which gives an improved skin sensation. The invention further relates to a simple production method and the use thereof for the care, treatment or mild cleansing of the skin, in particular also in the case of dysfunctional skin.

Description

IN THE MATTER OF an Australian Application corresponding to PCT Application PCT/EP2003/011528 RWS Group Ltd, of Europa House, Marsham Way, Gerrards Cross, Buckinghamshire, England, hereby solemnly and sincerely declares that, to the best of its knowledge and belief, the following document, prepared by one of its translators competent in the art and conversant with the English and German languages, is a true and correct translation of the PCT Application filed under No. PCT/EP2003/011528 Date: 27 January 2005 C. E. SITCH Deputy Managing Director - UK Translation Division For and on behalf of RWS Group Ltd WO 2004/039338 PCT/EP2003/011528 O/W EMULSION WITH A COMBINATION OF A SILICONE-BASED EMULSIFIER AND ONE OR SEVERAL SURFACTANTS SELECTED FROM ANIONIC AND CATIONIC SURFACTANTS, THE PRODUCTION AND USE THEREOF 5 Description The present invention relates to a, in particular foamable, composition with improved skin effect based on an O/W emulsion with a combination of a silicone 10 based emulsifier and a, in particular anionic, surfactant. With such a composition it is possible for stable emulsions, with or without propellant gas, to be distributed or effectively foamed during use; these can then be applied easily to the skin and there achieve in 15 particular a particularly fine distribution of the composition in the form of an emulsion, e.g. in the form of foam, and produce an improved feel on the skin. The invention further relates to a simple method for producing this and to the use for the care, treatment 20 or mild cleansing of the skin, in particular also in the case of dysfunctional skin. Prior art Foamable creams have hitherto been produced in various 25 ways with propellant gases possibly being obligatory depending on the composition. For example, DE 36 28 531.5 describes a foamable O/W based cream which functions only with certain propellant gases, and then only in the presence 30 exclusively of a nonionic surfactant if the composition has a viscosity of from 290 to 450 mPas. The emulsifiers/surfactants specified are in particular alkylpolyglycol phosphoric esters, glyceryl stearate and PEG derivatives thereof, emulsifiers based on 35 silicones are not envisaged. DE 196 45 320.8 describes foamable compositions which, besides an oil phase, obligatorily have light protection factors and a combination of three different -2 nonionic surfactants, namely glucose derivatives (esters), polyoxyethylated esters and glyceride esters. This reportedly achieves a higher light protection filter effect than hitherto, for which reason 5 electrolytes in particular are also required. DE 199 55 375.0 likewise relates to foamable sunscreen compositions in the form of an O/W emulsion, where, besides the light protection factors, a combination of a nonionic or self-emulsifying emulsifier and one or 10 several surfactants, in particular a glutamate or a zwitterionic betain, are present. The emulsifiers chosen are polyoxyethylene fatty acid esters, such as Arlatone®, Myrjo, self-emulsifying fatty alcohols (Lanetteo N) or mono-/diglyceride fatty acid esters 15 (Imwitor®) . Here, the oil phase, comprising the emulsifier, is mixed with the water phase and then the foam-forming surfactant is added, the emulsifier being present in the same amount as or a greater amount than the surfactant. 20 Emulsifiers based on polysiloxane are known, especially for the production of creams, lotions etc. They generally have good emulsifying properties and are suitable for sprayable products. One product which is 25 particularly known here is the commercial product known under the name Abil® Care 85, which is bis-PEG/PPG 16/16 PEG/PPG-16/16 dimethicone and is available as an approximately 85% strength solution in an oil such as caprylic/capric triglyceride. As such, it is used in 30 concentrations of from 1.5 to 3%. However, when producing emulsions, for reasons of stability, nonionic coemulsifiers such as TEGO@ SMO 80 V (polysorbate-80) (cold production, e.g. for sprays) or Teginacido C (ceteareth-25) (hot production e.g. for creams), and 35 stabilizers, such as xanthan gum, TEGO® Carbomer (cold production for emulsions or sprays) or stearyl alcohol, glyceryl stearate, stearic acid (hot production for creams) should be added, cf. SoWF (2002), 128, page 22- -3 31. Reference is made here in particular to the difficulties during the production of sprayable emulsions (page 23), for which reason these are also prepared cold and only using special stabilizers (see 5 above). However, to date still. no foamable products therewith have been described. EP-B 1 014 916 relates to alkali skin protection creams based on soap which must comprise at least one C10-22 fatty acid and emulsifiers and coemulsifiers which are 10 prepared by mixing the fatty phase heated to 250C together with fatty acid with the water phase heated to 750C and subsequently increasing the pH to > 7.2. EP-B 0 835 647 describes compositions in the form of a gel emulsion which, besides a fatty phase, have 0.1-2% 15 of a gel-forming system comprising, as gel emulsifier, a homopolymer based on acrylate or a copolymer based on ethylenically unsaturated monomers. For this purpose, gel formers such as xanthan gum, Carbomer® etc. should also be present. Surfactants, which are not described 20 in more detail, must only be present in an amount up to at most 2%. The product is after-foaming, i.e. it is not dispensed in the form of a foam. DE 100 59 239 Al relates to cosmetic and/or 25 pharmaceutical emulsions comprising long-chain (hydroxy) fatty acids, such as hydroxystearic acids, and oils and optionally emulsifiers which can be chosen from various groups. Among others, those based on polysiloxane polyalkyl are specified generally, with 30 none being mentioned according to the examples. Only oils based on siloxane are mentioned, namely di-/cyclo and/or cetyldimethicone. If O/W or, in particular, W/O emulsions are produced, polyglyceryl derivatives (Eumulgin VL 75*, Dehymuls PGPH ), for example, are 35 used as emulsifier. A foamability of such substances is stated nowhere. DE 100 48 683 describes W/O emulsions, where the emulsifiers used are alkyl(di)methicone copolyols, e.g.
-4 Abil EM 90. The compositions obtained in this way are merely referred to as sprayable. Object of the invention 5 It is therefore an object of the present invention to provide a composition which, with or without the use of propellant gases, is readily distributable, in particu lar foamable, and is easy to produce, and, even without the special use of complex emulsifier and/or surfactant 10 mixtures or obligatorily coemulsifiers/stabilizers or gel formers, leads to stable products. Attainment of the invention This object is achieved according to the invention by a 15 composition which, based on an 01W emulsion, is characterized in that it has 2 to 50% of an oil phase, 0.1 to 10% of one or several silicone-based emulsifier(s), 0.1 to 20% of one or several surfactant(s) chosen from anionic and cationic 20 surfactants, 0 to 40% of additives and water as the remainder. The composition is, in particular, foamable. Explanation of the invention With such a composition which is not based on an 25 alkaline soap base, it is surprisingly possible to prepare stable products, even without using special stabilizers, which are very readily distributed, in particular are foamable, during use as a result of foamability. As a result, on account of the very much 30 more finely distributed product compared with conventional applied emulsions, an improved effect on the skin is achieved and additionally due to the silicone emulsifier a particularly rich and smooth skin feel is generated. 35 The composition can comprise varying amounts of water, fatty phase, emulsifier and optionally additives. Then, depending on the intended use, a lotion, a fluid or a cream, for example, are obtained. The lotion can have, -5 for example, 70% water, and the cream 50% water. According to the invention, it is therefore not necessary- for nonionic surfactants, fatty acids, to be incorporated. These are therefore preferably 5 essentially not present. Preferably, 0.1 to 8%, in particular 0.5 to 5% of one or several emulsifiers based on silicone, 0.1 to 18%, in particular 0.3 to 15% of one or several surfactants are present. 10 These are in particular O/W silicone-based emulsifiers, in amounts as stated, in particular as described below. The amount of oil phase is preferably 3 to 35%, in particular 3 to 25% and very particularly preferably 4 to 25%. 15 It is particularly preferred if one or several polysiloxane-polyether copolymers (dimethicone copolyols) are present as emulsifier, namely O/W emulsifiers in particular. Of these, one or several polyethylene glycol (PEG)-/polypropylene glycol (PPG) 20 polysiloxane copolymers with varying amounts of PEG and PPG of in each case 1-20 units based on a polyether block in the ratio 1:0 to 0.9:1, in particular 1:0 to 1:1 are very particularly suitable. These include in particular the PEG/PPG dimethicones in 25 the form of O/W emulsifiers. These include in particular PEG/PPG-20/6 dimethicones, bis-PEG/PPG-20/20 dimethicones, PEG-12 or PEG-14 dimethicones, PEG/PPG-14/4 or 14/12 or 14/14 or 20/20 or 18/18 or 17/18 or 15/15 dimethicones, bis-PEG/PPG 30 16/16 PEG/PPG-16/16 dimethicones or mixtures thereof. Of particular suitability here are the products known under the name Abil®, such as, for example, Abil® Care 85 = bis-PEG/PPG-16/16 PEG-PPG-16/16 dimethicones (e.g. 85% strength in caprylic/capric triglyceride). 35 In addition, the silicone polyethers known under the name Abil® 8842 (1:0), 8843 (1:0), 8851 (1.4:4); 8852 (1.4:1.2); 8863 (1:1); and Dow Corning® 193 (1:0) are also particularly suitable.
-6 These silicone-based emulsifiers can be used as they are or else in the form of solutions/dispersions in oils, such as, for example, triglycerides, in particular medium-chain triglycerides or else suitable 5 other oils, such as silicone oils. They are, for example, in amounts of from 40 to 90%, preferably 55 to 90%, and 85% strength solutions in caprylic/capric triglyceride are particularly suitable. 10 The oil phase comprises in particular customary, preferably liquid or wax-like, lipids. These may be present individually or in a mixture. In particular, the following groups and examples are suitable for this purpose: 15 Hydrocarbons, such as squalene, squalane, in particular also liquid paraffins, isoparaffins, dioctylcyclohexanes (Cetiolo S), isohexadecanes (Arlamol& HD); fatty alcohols, such as oleyl alcohol, octyldodecanol (Eutanol G); fatty acid esters, e.g. 20 isopropyl fatty acid esters (palmitate, myristate, isostearate, oleate), decyl oleate (Cetiol@ V), hexyl laurate, C12-15 alkyl benzoate (Finsolv® TN), dicaprylyl carbonate (Cetiole CC), diesters such as dibutyl adipate (Cetiol* B), propylene glycol 25 dipelargonate, branched fatty acid esters such as PCL liquid (cetearyl octanoate) or mixtures such as Cetiol PGL (hexyldecanol and hexyldecyl laurate), fatty alcohol ethers such as dicaprylyl ether (Cetiol* OE) or fatty alcohol esters such as C12-13 alkyl 30 lactate (Cosmacol ELI). Polyol fatty acid esters such as Cetiol® HE (PEG-7 glyceryl cocoate) triglycerides, in particular medium-chain (neutral oils) such as caprylic/capric triglycerides (Miglyol@ 35 810, 812) and polyol esters thereof, such as propylene glycol dicaprylate/dicaprate (Miglyol® 840) Natural fats and oils, such as sunflower oil, soya oil, peach kernel oil, apricot kernel oil, grape seed oil, -7 castor oil, peanut oil, almond oil, mink oil, wheat germ oil, avocado oil, shea butter (e.g. Cetiol* SB 45) or illip6 butter (Lipex® 106). Natural liquid waxes, e.g. jojoba oil or its substitute 5 oleyl erucate (Cetiol® J 600) Silicone oils and waxes, e.g. polydimethylsiloxanes such as Dow Corning Fluid® 200 dimethiconee), cyclomethylsiloxanes such as Dow Corning Fluid® 345 (cyclopentasiloxane), phenylmethylpolysiloxanes, such 10 as phenyl dimethicone (Abil® AV 8853) or alkyl polymethylsiloxane copolymers such as cetyl dimethicone (Abil® Wax 9801), stearyl dimethicone (Abil® Wax 9800), dialkoxydimethylpolysiloxanes such as stearoxy dimethicone (Abil® Wax 2434), behenoxy dimethicone 15 (Abil® Wax 2440) Waxes such as natural or bleached beeswax (Lunacera® alba), Kester® wax K82H (C 2 0 -4o-alkyl stearate) or Lunacerao M (microwax) or hydrocarbon waxes such as Lunacera® P (mineral wax) and hydrogenated castor oil 20 (Cutina® HR) or synthetic waxes, such as cetyl palmitate (Cutina® CP) or myristyl myristate (Crodamol® MM), or stearyl stearate (Crodamol@ SS). The fatty (oil) phase is preferably chosen from hydrocarbons, fatty alcohols, ethers and esters, 25 (polyol) fatty acid esters, triglycerides, natural oils, natural fats, waxes, silicone oils and silicone waxes or mixtures thereof. Particular preference is given here to liquid paraffins, triglycerides, fatty alcohol ethers, vegetable oils, silicone oil or 30 mixtures thereof. Particularly preferred oil components are liquid paraffins, fatty acid esters, such as isopropyl palmitate or myristate, medium-chain triglycerides such as the abovementioned miglyols, and the specified 35 natural fats and oils, in particular illip6 butter, shea butter, grape seed oil, peach kernel oil, apricot kernel oil, in particular mixtures thereof, and jojoba oil, mixtures thereof with the abovementioned -8 components, where in each case about 1-50% of individual components, based on the total amount, are present or fatty alcohol ethers or fatty alcohols or mixtures thereof or hydrogenated oils such as 5 perhydrosqualene individually or combined. Particular preference is given to the specified liquid paraffins, triglycerides, fatty alcohol ethers, Shea butter and silicone oils, also in combination with one another, where about 1-50% of individual components, 10 based on the total amount of oil, may be present. In addition, silicone waxes are also particularly suitable, especially also combinations thereof and also with the abovementioned paraffins, fatty alcohol ethers and Shea butter. 15 In addition, the abovementioned dioctylcyclohexanes, isohexadecanes, in particular the latter, silicone oils and waxes are also particularly suitable, in particular also combinations thereof and also with the abovementioned fatty alcohol ethers and triglycerides. 20 These can then in particular also be combined with the natural fats, oils and waxes. It is also preferred if the additives are chosen from active ingredients, stabilizers, dyes, perfume 25 substances, consistency regulators, care substances, cosurfactants and preservatives. Of these, 0.01 to 30%, in particular 0.5 to 20%, in particular, are present. Suitable surfactants are anionic and cationic 30 surfactants. Of suitability here are the surfactants known in these groups. Preferably, one or several anionic surfactants are chosen as surfactants. These include alkyl sulfates and 35 alkyl ether sulfates, in particular with 1-6 ethylene oxide groups in the molecule, and alkyl sulfosuccinates, and alkyl ethoxysulfosuccinates, alkyl sulfosuccinamates, alkyl sarcosinates, isethionates, -9 taurides, ether carboxylic acids, alkylsulfonates and alkylbenzenesulfonates, a-olefinsulfonates, alkyl sulfoacetates, where in the alkyl moiety in particular 8-22, preferably up to 18, carbon atoms are present. 5 In particular, those chosen from alkyl sarcosinates, alkyl sulfates, alkyl ether sulfates, alkyl sulfosuccinates, alkyl sulfosuccinnamates, isethionates, or alkali metal salts thereof or mixtures thereof are suitable. These have in particular 8 to 22, 10 preferably 8 to 16, carbon atoms in the alkyl chain. Particular preference here is given to alkyl ether sulfates which are derived from fatty alcohols having 12 to 18 carbon atoms and a degree of ethoxylation of from 2 to 6, such as, for example, lauryl/myristyl 15 ether sulfate, Na salt (e.g. Texapon@ K 14 S special IS, Hansanolo NS 243), ammonium lauryl ether sulfate (Zetesol® LA-2) or monoisopropanolammonium lauryl ether sulfate (Zetesol" 2056) or alkyl sulfates, e.g. sodium lauryl sulfate (Texapon® Z), ammonium lauryl sulfate 20 (Texapon® ALS, Sulfetal@ LA) or monoisopropanolammonium lauryl sulfate (Sulfetals CJOT 60). Very particular preference is given to one or several alkyl sarcosinates, such as sodium lauroyl, cocoyl or oleyl sarcosinates, and one or several alkyl 25 sulfosuccinates as described below, as given above, or mixtures thereof. In particular, alkyl sarcosinates such as Medialan® LD, Crodasinic*LS 30, (sodium lauroyl sarcosinate) or succinic acid derivatives, such as alkyl 30 sulfosuccinates and alkyl sulfosuccinamates with an alkyl radical of from 8 to 22 carbon atoms, e.g. Wallasol@-L 29 (disodium laureth-3 sulfosuccinate) are also suitable on their own. In particular, the specified alkyl sarcosinates are 35 preferred. The cationic surfactants used are, esterquats, such as behentrimonium methosulfate. The abovementioned surfactants can be used as they are - 10 or in combination with suitable solvents, which are governed by the nature of the surfactant. It is thus possible to use solutions, in particular aqueous solutions, of 20-90%, preferably 25-70%, in particular 5 28-50%. The ratio of emulsifier to surfactant, in each case based on the total amount, is very particularly preferably 1:0.2 to 1:15, but especially 1:0.5 to 1:10 and in particular 1:0.7 to 1:7. 10 The amount of surface-active substances, in particular the sum of emulsifier(s) + surfactant(s) can also suitably be greater than 1.4%, or else greater than 2%. Very particularly, compositions which comprise the emulsifier or the emulsifiers in a total amount of from 15 0.2 to 5%, especially 0.5 to 5%, in particular and the surfactant or the surfactants in a total amount of from 0.5 to 15% are also suitable. Compositions with 1 to 30% of oil phase are also particularly suitable. 20 As mentioned, it is desirable if additives which have lipophilic and/or hydrophilic character are present. These include, in particular, active ingredients, e.g. 0.01 to 80%, in particular up to 50, preferably up to 25 25%, based on the total amount of additives or 0.01 to 10%, based on the composition. These active ingredients are chosen in particular from extracts from plants, synthetically produced substances corresponding to these extracts and analogous derivatives thereof, 30 vitamins, and active ingredients which influence the skin, and mixtures thereof. Extracts from plants are, for example, those from ylang-ylang, pine needle, cypress, thyme, mint, limes, oranges grapefruit, mandarins, juniper, valerian, lemon 35 balm, eucalyptus, thyme, palmarosa, rosemary, lavender, rosewood, lemon grass, fir needle, pine needle, ginger extract, currant extract, linden blossom extract, marigold extract, magnolia extract, algae extract, Aloe - 11 Vera extract, pineapple extract, guava extract, Echinacea extract, ivy leaf extract or mixtures thereof. . These extracts can be produced, for example, by steam 5 distillation. This gives, for example, essential oils from the specified plants which are particularly preferred. The extracts can also be obtained in other known ways by, for example, solvent extraction (with alcohols, 10 triglycerides or hydrocarbons, water, mixtures thereof) and then be used as such. Analogous synthetically produced substances are, for example, terpenes and terpenoids, such as camphor, menthol, cineol or mixtures thereof. 15 Suitable vitamins are, for example, vitamin A, E, C and suitable derivatives thereof, such as esters, e.g. palmitate, acetate or phosphate. Also suitable are mineral substances and trace elements, such as copper, zinc, or derivatives thereof 20 such as Zincidonee (zinc PCA), zinc gluconate or copper gluconate. It is also possible to use astringent and sebum regulating substances, such as Acnacidol® 101 (propylene glycol, hydroxydecanoic acid) , Asebiol® BT 25 (hydrolyzed yeast protein, pyridoxine, niacinamide, glycerol, panthenol, propylene glycol, allatoin, biotin), Lipacidee C8CO (caproyl collagen amino acids), Sebosoft& (glycerol, aqua, PEG-8, caprylyl glycol, sebacic acid, sodium polyacrylate), Sepi Control A5 30 (capryloylglycine, methylglycine, cinnamonum zeylanicum). Additional active ingredients which may also be present are further plant extracts, e.g. birch leaf extract, Aloe Vera extract, marigold extract, hibiscus extract, 35 stinging nettle extract, hamamelis extract, Gotu kola extract, algae extract, quince extract, waterlily extract, cinnamon extract. It is also possible to incorporate cooling/calming - 12 active ingredients, such as Frescolat® ML (menthyl lactate) or Eashave (sodium hyaluronate, wheat germ extract, Saccharomyces cerevisiae extract). Moreover, additives which can be used are substances 5 which promote circulation, e.g. nicotinic acid derivatives, such as methyl or tocopheryl nicotinate, alpha- and beta-hydroxy acids and derivatives thereof, e.g. glycolic acid, maleic acid, citric acid, tartaric acid, lactic acid, salicylic acid, isopropylbenzyl 10 salicylates, C12-13 alkyl lactates (Cosmacol ELI) or else antiphlogistic and antibacterial substances, such as triterpenes, e.g. ursolic acid, glycyrrhizinic acid or glycyrrhetinic acid and derivatives thereof, e.g. stearyl glycyrrhetinate, potassium glycyrrhinate; 15 pantothenic acid derivatives, e.g. D-panthenol, panthenyl triacetate; allatoin; bisabolol; azulenes, e.g. chamazulene or guaiazulene; phytosphingosines; triclosan; chlorhexidine derivatives and/or antidandruff agents, e.g. climbazole or piroctone 20 olamine. In addition, in the compositions according to the invention is also possible to use substances with an antioxidative and cell-protective effect, such as polyphenols, flavonoids, e.g. rutin, ferulic acid and 25 esters thereof or isoflavones such as soya isoflavones or coenzyme Q 10, as effective additives. Further active ingredients are UV filters, such as UVB, UVA and broadband filters of the following type: UV-B filters: cinnamic esters, e.g. ethylhexyl 30 methoxycinnamate (Eusolex® 2292, Neo Heliopan@ AV, Parsol @ MCX), isoamyl p-methoxycinnamate (Neo Heliopano Galanga) and 4-methylbenzylidenecamphor (Eusolex® 6300), paraaminobenzoic acid and esters, such as 2 ethylhexyl N,N-dimethyl-4-aminobenzoate (Eusolex® 6007, 35 octyl dimethyl PABA), homomenthyl salicylate (homosalate, Eusolex® HMS), octyl salicylate (Neo Heliopano OS), octocrylene (Neo Heliopan@ 303), phenylbenzimidazolesulfonic acid (Neo Heolipan® Hydro, - 13 Eusolex® 232) or benzylidene malonate polysiloxane (Parsol SLX); UVA + UVB filters for broadband absorption, such as benzophenone-3 (Neo® Heliopan BB, Eusolex® 4360). 5 UV-A filters, such as methyl anthranilate (Neo Heliopan MA), butylmethoxydibenzoylmethane (Parsol 1789, Eusolex® 9020), methylenebisbenzotriazolyl tetra methylbutylphenol (Tinosorb@ M), bis-ethylhexyloxy phenol methoxyphenyltriazine (Tinosorb@ S), disodium 10 phenyldibenzimidazoletetrasulfonate (Neo Heliopan® AP), 2-(4-diethylamino-2-hydroxybenzoyl)benzoic acid hexyl ester (Uvinul® A Plus) Particular preference is given to benzylidene malonate polysiloxane, octyl or isoamyl p-methoxycinnamate, 15 octocrylene, 4-methylbenzylidenecamphor, homosalate and/or butylmethoxydibenzoylmethane and/or benzo phenone-3. Also suitable are inorganic UV filters, such as zinc oxide and titanium dioxide in particular micronized and/or coated, e.g. Z-Cote*, Tioveil®, 20 Solaveil® or Unititamer® T 40. Depending on the envisaged effect, such as, for example, calming, improving the skin structure, increasing circulation, relaxing, aromatherapy and 25 others, a suitable combination of active substances can be added. Particularly preferred active substances are essential oils from ylang-ylang, lemon grass, mint, oranges, grapefruit, lime, mandarins, cypress, thyme, lavender, rosemary, ginger, or mixtures thereof. 30 In addition, the specified vitamins and/or panthenol in particular are used, especially in combinations with the plant extracts or essential oils. Particularly desired active ingredients are chosen from 35 vitamins, UV filters or dermatological active ingredients, e.g. antimycotics such as naftifine HCl, terbinafine HCl or antioxidative, antibacterial and/or sebum-regulating substances.
- 14 Moreover, the composition according to the invention can comprise, as further additives, dyes, conditioners, care substances, preservatives, perfume substances, 5 stabilizers, consistency regulators. These may be present in particular in the following amounts: conditioners, e.g. 0.01 to 5%; stabilizer(s), e.g. 0.01 to 5%, in particular 0.05 to 3%, preservatives, e.g. 0.01 to 5%, in particular 0.1 to 5%; consistency 10 regulators, e.g. 0.01 to 10%; care substances, e.g. 0.01 to 10%; dyes 0.0005 to 3%, perfume substances, e.g. 0.01 to 5%. Care substances (e.g. preferably 0.01 to 20%, in 15 particular from 0.01 to 10%) which are one or several lecithins or derivatives thereof, such as, in particular, lecithin, phospholipids, such as phosphatidylcholine, and ceramides, such as, for example, ceramide-2, -3, -6 and sphinogolipids, such 20 as, for example, Proceramide® L, Ceraderm® S, Ceraveg Particularly suitable care substances are also phytosterols (essentially mixtures of 0-sitosterol, campesterol and stigmasterol), such as those from rapeseed oil (Generol® R). 25 Particular preference is given to lecithin (e.g. soya lecithin), phosphatidylcholine, phosphatidylserine or -diethanolamine, the abovementioned Generols® or mixtures thereof. It is also possible to use silicone oils, e.g. 30 dimethicones or silicone (co)polymers, e.g. Dow Corning HMW 2220 (divinyldimethicone/dimethicone copolymer, C12-13 pareth-3/C12-13 pareth-23). Further care substances are moisturizers such as glycerol, propylene glycol or polyethylene glycol, 35 propylene glycol, butylene glycol, sorbitol or polymers, e.g. polyquaternium grades such as polyquaternium-39 (Merquat® plus 3330), proteins, such as collagen or its hydrolysates, amino acids, urea, - 15 plant proteins, such as, for example, from wheat, soya or almond or hydrolysates thereof, e.g. Tritisol* (hydrolyzed wheat protein), Promois 0 WK (hydrolyzed keratin), Promois ® Milk (hydrolyzed casein), Wheat 5 Tein@ AA (hydrolyzed wheat protein), Lactolan® LS-5879 (hydrolyzed milk protein), polysaccharides, such as, for example, Fucogel 1000 (biosaccharide gum-1), glucosaminoglycans, e.g. hyaluronic acid or sulfated glucosaminoglycans, such as chondroitin sulfate, 10 dermatan sulfate, karatan sulfate, heparan sulfate, in particular Na salts thereof or heparin Na, glucans, e.g. -glucan, e.g. oat P-glucan (Drago-p-Glucan®), mannans, such as konjac mannans, algae extracts, e.g. Seanamin® SU or commercially available moisturizers, 15 such as, for example, Hydractin (glycerol, aqua, disodium adenosine triphosphate, algin, carica papaya) or Aquaderme (sodium PCA, sodium lactate, fructose, glycine, niacinamide, urea, inositol), salts, e.g. sodium lactate, DL-2-pyrrolidone-5-carboxylic acid, Na 20 salt. Preference is given to polyethylene/propylene glycol or glycerol in amounts of, for example, 0.5-10%, in particular 2-5%, and polysaccharide compounds such as Fucogel 1000, algae extracts and/or hyaluronic acid, 25 Na salt. Stabilizers (e.g. preferably 0.01 to 5%) which may be present are, for example, complexing agents such as Trilon® BD (EDTA, Na salt), agents for adjusting the 30 pH, e.g. citric acid, sodium hydroxide solution, solvents, such as propylene glycol or alcohols, starch, or starch derivatives or mixtures thereof. The compositions according to the invention are, in particular, neutral and skin-friendly and in as much 35 preferably have a pH of < 7.2, in particular 7, in correlation with, optionally, pH-sensitive additives and/or active substances. Suitable starch or starch derivatives are, in - 16 particular, the following substances: Rice, wheat, corn and potato starch. Particular preference is given to hydrophobically modified starches, such as Dry Flo@ AF (corn starch 5 modified), aluminum starch octenylsuccinate (Dry Flo@ PC, Fluidamid® DF 12), hydroxypropyl starch phosphate ester (Sturcture XL) or mixtures thereof such as Natrasorb® HFB (aluminum starch octenylsuccinate, acrylates copolymer, magnesium carbonate), ASO/MM3® 10 (aluminum starch octenylsuccinate, magnesium myristate), Dry Flo® Elite LL (aluminum starch octenylsuccinate, lauroyl lysine), Facemat® (aluminum starch octenylsuccinate, mica, Zea Mays (corn) starch, silica, titanium dioxide, zinc oxide). 15 Very particular preference is given to Dry Flo® PC or AF and Natrasorb® HFB. Other stabilizers are, in particular, anionic cosurfactants, such as glutamates, e.g. sodium cocoyl glutamate (Hostapon® CCG) or mono- and dialkyl 20 phosphates or self-emulsifying glyceryl stearate. In addition, one or several preservatives and consistency regulators (preferably, for example, in each case 0.01 to 5%) may optionally be present. 25 Suitable preservatives are, for example, iodopropynyl butylcarbamate, DMDM hydantoin, phenoxyethanol and further customary preservatives, such as, for example, sorbic and dehydracetic acid and salts thereof, methyldibromoglutanonitrile, etc. or combinations 30 thereof, or other acids, such as benzoic or salicylic acid, or benzyl alcohol or esters, such as p hydroxybenzoic esters, e.g. methyl-, ethyl-, propyl-, butyl-, isobutylparaben, preferably methyl- or propyl paraben or mixtures thereof or climbazole or suitable 35 combinations of the specified substances, such as, for example, methyl-, propylparaben and sorbic acid. Mixtures, e.g. of DMDM hydantoin and iodopropynyl butylcarbamate, such as Glydant® plus or of - 17 phenoxyethanol with p-hydroxybenzoic esters such as Phenonip, isothiazolinones, methyldibromoglutano nitriles, etc. are particularly suitable. 5 Suitable consistency regulators (e.g. preferably 0.01 to 5%) are gel formers, such as acrylamides or acrylates, and polysaccharides such as Keltrol® (xanthan gum), cellulose derivatives, such as hydroxy propyl methyl cellulose (Methocel® J12-MS) or ethyl 10 cellulose or silicates, such as magnesium aluminum silicate (Veegum® HV). Preferred acrylamides are polyacrylamide, e.g. Flocare® T 920 GC or polyacrylamide-containing mixtures, such as Sepigel® 305 (polyacrylamides, C13-14 isoparaffin, 15 laureth-7), Sepigel 501 (acrylamides copolymer, mineral oil, C13-14 isoparaffin, polysorbate 85), Sepigel 502 (C13-14 isoparaffin, isostearyl isostearate, sodium polyacrylate, polyacrylamide, polysorbate 20), Creagel® EZ DC (polyacrylamide, 20 polydecene, dimethicone copolyol), Creagel® EZ 5 (polyacrylamide, polydecene, laureth-5). The acrylates used are carboxy-vinyl mixed polymers with a high molecular weight (1-3 million), and copoly mers thereof, in particular following neutralization by 25 alkali. Preference is given to the Carbopol® grades known under the INCI name Carbomer, e.g. Carbopol® 910, 934, 940, 941, 954, 980, 981, 2984, 5984 or Carbopol® ETD 2001, 2050 or Synthalen@ K, L, M or the already neutralized carbomers such as PNC® 400, 410, 430 (INCI: 30 Sodium Carbomer) . It is also possible to use acrylate copolymers, e.g. acrylates/C1O-30 alkyl acrylate cross polymer, known as Carbopol® 1342, 1382, ETD 2020, Pemulen® TR-1, TR-2. Acrylamidoalkylsulfonic acid deri vatives, such as ammonium acryloyldimethyltaurate/VP 35 copolymer (Aristoflex® AVC) are particularly preferred. Further suitable consistency regulators are, for example, fatty alcohols, such as stearyl alcohol - 18 (Lanette® 18), cetyl alcohol (Lanette® 16), myristyl alcohol (Lanette® 14) or cetearyl alcohol (Lanette® 0) are chosen. Also suitable are glyceryl esters, such as glyceryl stearate, in particular glycerol monostearate 5 or glycerol distearate or mixtures thereof, e.g. Tegin® M. In addition, bodying agents which can be used are also the abovementioned waxes. Particularly preferred bodying agents are the 10 abovementioned fatty alcohols, such as stearyl alcohol (Lanette® 18), cetyl alcohol (Lanette® 16), myristyl alcohol (Lanette® 14) or cetearyl alcohol (Lanette® 0), in particular in combination with acrylates such as Aristoflex® AVC or carbomers. 15 Suitable perfume substances (e.g. preferably 0.01 to 5%) are, for example, the essential oils specified under active substances, or standard commercial perfume mixtures. 20 The dyes (e.g. preferably 0.01 to 2%) chosen are preferably the components known for generic products, such as, for example, Patent Blue, Amidoblue, Orange RGL, cochineal red, quinoline yellow. 25 The type and amount of additives is governed by the desired application form and the desired purpose. It is preferred if at most 25%, preferably 0.01 to 20%, especially also 0.01 to 20% or 1 to 18%, in particular 30 5 to 15%, of additives are present. Particular preference is given to choosing stabilizers, dyes, antioxidants, perfume substances, consistency regulators, care substances, optionally preservatives or mixtures thereof, with particular preference being 35 given to care substances and stabilizers.. Preference is given to preservatives, optionally in combination with active substances and/or pH regulators as additives. Particular preference is given to 0.01 to 25% of - 19 additives which are chosen in particular from active substances, care substances, stabilizers, dyes, perfume substances, consistency regulators. Of these, consistency regulators, such as fatty 5 alcohols, acrylate polymers, such as Aristoflex® AVC or carbomers and/or acrylate copolymers, cellulose derivatives, stabilizers such as starch derivatives, in particular Dry Flo AF cosurfactants, such as glutamates, and/or moisturizers, conditioners are very 10 particularly suitable. In particular, fatty alcohols, cellulose derivatives or mixtures thereof are suitable as consistency regulators. The care substances used are in particular moisturizers such as glycerol and/or polymers and/or 15 polysaccharides. Suitable perfume substances and/or dyes are primarily compositions, or dyes customary for cosmetics, and particularly preferred active ingredients are vitamins and plant extracts, UV filters, antioxidative 20 substances, panthenol and/or allantoin and/or mineral substances and derivatives thereof. The composition according to the invention may be contained in and dispensed from devices customary for 25 emulsions. Upon leaving and rubbing on/with air, the finely distributed, finely bubbled or optionally foam like product, as described, is produced on the skin. According to the invention, the in particular foamable composition can preferably be in the form of a foam. 30 For this purpose, it can, for example, be contained in a foam dispenser with a suitable pump mechanism or else together with a suitable propellant gas in an aerosol device. Here, the product is obtained directly as foam and is not after-foaming, as described in the above 35 prior art. The aerosol device can have a pressurized gas container with propellant, a distributor device with valve, spray head, and the composition. Suitable propellant gases are commercial gases or gas - 20 mixtures customary for this purpose, such as C0 2 , N 2 ,
N
2 0 or mixtures thereof, such as C0 2
:N
2 0 1:1 to 0.5:1. Very particular preference is given to gases such as butane/propane/isobutane or mixtures thereof, as are 5 commercially available for aerosols, e.g. a 3-5:20-25:65-73, as available, for example, as Drivosol@ (35A). The gas may be present in compressed form in amounts of from 2 to 20%, preferably 3-13%, in particular 4-8%, based on the finished product. 10 However, the quantitative ratios can also be varied in other ratios depending on the total amount of the product and the size of the container. Suitable devices for administering the composition according to the invention in the form of an aerosol 15 are known, as are those for application free from propellant gas. In this connection it is possible, for example, to use mechanical foam dispensers operating according to the principle of an air pump, such as Squeeze Foamer (F2 finger pump foamer, commercially 20 available), Rieke dispensing from Englass or Foamer from Airspray, the finished emulsion in each case being bottled in a suitable manner. The composition is preferably contained in conventional dispensing vessels. In particular, it is dispensed from a foam 25 dispenser or an aerosol container filled with propellant gas. Preparation The compositions according to the invention are 30 prepared by mixing the oil phase, the emulsifier or the emulsifiers, optionally together with thermally stable oil-soluble additives and optionally heating to 50 to 85 0 C and then adding the aqueous phase, optionally heated to 50 to 85*C and comprising water, the 35 surfactant or the surfactants and optionally thermally stable additives, with stirring and then, if necessary, cooling the resulting emulsion and, if present, adding thermally labile additives. The emulsion prepared in - 21 this way can then be bottled in a known manner into suitable containers for administration, e.g. from customary dispensers, dispensing devices or vessels, or for dispensing in foam form into the above-described 5 pump dispensers or aerosol containers. Use In particular, the composition according to the invention can be used for the care, the cosmetic or 10 dermatological treatment of skin for freshening, reviving, moisture regulation, calming or for mild cleansing, in particular also in the case of dysfunctional, especially dry or low-moisture, skin, or else for protection of the skin. The effect, which can 15 be aided by corresponding additives as described above, is achieved in particular through the particularly fine distribution of the composition in the form of an emulsion, e.g. especially in the form of a foam, where, moreover, an improved skin feel is unexpectedly 20 produced through the use of the emulsifier together with the specified surfactants. As mentioned, the product can be dispensed by means of conventional dispensing vessels, dispensers, by means of a device with a pump mechanism or from containers 25 containing aerosol. It is assumed, without laying down such an explanation, that on account of the combination according to the invention the physicochemical properties of the composition are such that the fine distribution of the product upon use occurs as a result 30 of rubbing on/with air/aerosol, i.e. through the possibility of the formation of foam. The product can therefore be applied as such or in the form of a foam. Examples 35 The invention is explained in more detail by reference to the examples below. The individual ingredients have the following meanings: Trilon® BD = disodium EDTA - 22 Abil® Care 85 = bis-PEG/PPG-16/16 PEG/PPG 16/16 dimethicone, about 85% strength in caprylic/capric triglyceride Oxynex 2004 = propylene glycol, BHT, ascorbyl 5 palmitate, glyceryl stearate, citric acid Hostapon CCG = sodium cocoyl glutamate, about 30% strength aqueous solution Medialan® LD = sodium lauroyl sarcosinate, about 30% strength aqueous solution 10 Phenonip = phenoxyethanol, methylparaben, ethylparaben, propylparaben, butylparaben, isobutylparaben AristoflexS AVC = ammonium acryloyldimethyltaurate/VP copolymer 15 Seanamin* SU = aqua, sorbitol, algae, Chondrus crispus, Fucus vesiculosus, algin; Fucogel@ 1000 = biosaccharide gum-1 Merquat@ plus 3330 = polyquaternium-39, about 9.5% strength aqueous solution 20 Dry Flo® AF = corn starch modified PNCO 430 = sodium carbomer Hansanol® NS 243 = sodium laureth sulfate, about 28% strength aqueous solution Brij@ 721 = steareth-21; Tweeno 80 = polysorbate-80 25 Hostaphat@ KW 340 D = triceteareth-4 phosphate Examples 1 to 7 represent compositions according to the invention which all exhibit good foam formation with small-pored foam which does not rapidly collapse, and 30 stability. Examples 8 to 11 are comparative examples as described below comprising nonionic surfactants. Example 1 Raw materials 100% formulation Aqua purificata 59.96 Trilon® BD 0.05 Glycerol 7.00 - 23 Citric acid 0.04 Abil0 Care 85 3.00 Cetearyl alcohol 2.00 Isohexadecane 6.00 Dicaprylyl ether 4.00 Stearyl dimethicone 3.00 Shea butter 5.00 Oxynex® 2004 0.05 Medialan® LD 2.00 Phenonip® 0.90 Aqua purificata 3.00 Fucogel 1000 3.00 Merquato Plus 3330 1.00 TOTAL 100.00 Example 2 Raw materials 100% formulation Aqua purificata 59.96 Trilon® BD 0.05 Glycerol 7.00 Citric acid 0.04 Abil® Care 85 1.00 Cetearyl alcohol 2.00 Isohexadecane 6.00 Dicaprylyl ether 4.00 Stearyl dimethicone 3.00 Shea butter 5.00 Oxynex 2004 0.05 Medialan® LD 4.00 Phenonip@ 0.90 Aqua purificata 3.00 Fucogelo 1000 3.00 Merquate Plus 3330 1.00 TOTAL 100.00 5 Example 3 - 24 Raw materials 100% formulation Aqua purificata 58.46 Trilon® BD 0.05 Glycerol 7.00 Citric acid 0.04 Abil® Care 85 1.00 Cetearyl alcohol 2.00 Isohexadecane 6.00 Dicaprylyl ether 4.00 Stearyl dimethicone 3.00 Shea butter 5.00 Oxynex® 2004 0.05 Hostapone CCG 2.00 Medialan® LD 2.00 PNC@ 430 0.50 Phenonip® 0.90 Aqua purificata 3.00 Fucogel® 1000 3.00 Merquato Plus 3330 1.00 Dry Flo@ AF 1.00 TOTAL 100.00 Example 4 Raw materials 100% formulation Aqua purificata 65.71 Trilon® BD 0.05 Glycerol 7.00 Citric acid 0.04 Xanthan gum 0.50 Abil® Care 85 0.50 Cetearyl alcohol 2.50 Dicaprylyl-dimethicone 3.00 Shea butter 5.00 Grape seed oil 1.00 Tocopherol acetate 1.00 - 25 Oxynex" 2004 0.05 Hostapon CCG 2.00 Medialan® LD 2.00 Aristoflex® AVC 0.25 Phenonipa 0.90 Aqua purificata 3.00 Seanamin® SU 3.00 Merquat Plus 3330 1.00 Dry Flo® AF 1.00 Perfume oil 0.50 TOTAL 100.00 Example 5 Raw materials 100% formulation Aqua purificata 61.96 Trilon® BD 0.05 Glycerol 7.00 Citric acid 0.04 Abil® Care 85 1.00 Cetearyl alcohol 2.00 Isohexadecane 6.00 Dicaprylyl ether 4.00 Stearyl dimethicone 3.00 Shea butter 5.00 Oxynex® 2004 0.05 Wallasol® L-29 2.00 Phenonipa 0.90 Aqua purificata 3.00 Fucogel 1000 3.00 Merquate Plus 3330 1.00 TOTAL 100.00 5 Example 6 Raw materials 100% formulation Aqua purificata 61.96 - 26 Trilon® BD 0.05 Glycerol 7.00 Citric acid 0.04 Abil® Care 85 1.00 Cetearyl alcohol 2.00 Isohexadecane 6.00 Dicaprylyl ether 4.00 Stearyl dimethicone 3.00 Shea butter 5.00 Oxynex@ 2004 0.05 Hansanol® NS 243 2.00 Phenonip@ 0.90 Aqua purificata 3.00 Fucogel® 1000 3.00 Merquat Plus 3330 1.00 TOTAL 100.00 Example 7 Raw materials 100% formulation Aqua purificata 70.81 Trilon® BD 0.05 Glycerol 7.00 Xanthan gum 0.50 Citric acid 0.04 Abil@ Care 85 1.00 Cetearyl alcohol 1.00 Oxynex* 2004 0.05 Decyl oleate 2.00 Paraffin, low viscosity 8.00 Hostapon® CCG 1.00 Medialan® LD 2.00 Phenonip® 0.90 Aristoflex® AVC 0.50 Aqua purificata 3.00 Merquat@ Plus 3330 1.00 Dry Flo@ AF 1.00 - 27 Perfume oil 0.15 TOTAL 100.00 Example 8 Raw materials 100% formulation Aqua purificata 61.96 Trilon® BD 0.05 Glycerol 7.00 Citric acid 0.04 Abil® Care 85 1.00 Cetearyl alcohol 2.00 Isohexadecane 6.00 Dicaprylyl ether 4.00 Stearyl dimethicone 3.00 Shea butter 5.00 Oxynex® 2004 0.05 Hostaphat KW 340 D 2.00 Phenonip@ 0.90 Aqua purificata 3.00 Fucogel@ 100 3.00 Merquat Plus 3330 1.00 TOTAL 100.00 5 Example 9 Raw materials 100% formulation Aqua purificata 61.96 Trilon® BD 0.05 Glycerol 7.00 Citric acid 0.04 Abil® Care 85 1.00 Cetearyl alcohol 2.00 Isohexadecane 6.00 Dicaprylyl ether 4.00 - 28 Stearyl dimethicone 3.00 Shea butter 5.00 Oxynex® 2004 0.05 Brij 721 2.00 Phenonip® 0.90 Aqua purificata 3.00 Fucogel@ 100 3.00 Merquat Plus 3330 1.00 TOTAL 100.00 Example 10 Raw materials 100% formulation Aqua purificata 79.80 Tween® 80 0.20 Abil® Care 85 3.00 Caprylic/capric triglyceride 10.00 Isohexadecane 5.00 Aristoflexe AVC 0.30 Xanthan gum 0.10 Paraffin, low viscosity 1.60 TOTAL 100.00 - 29 Example 11 Raw materials 100% formulation Aqua purificata 79.80 Tween® 80 0.20 Abil® Care 85 3.00 Caprylic/capric triglyceride 10.00 Isohexadecane 5.00 PNC® 400 0.30 Xanthan gum 0.10 Paraffin, low viscosity 1.60 TOTAL 100.00 The particular fine distribution of the composition according to the invention was analyzed by reference to 5 the foamability. The products in accordance with the application corresponding to Examples 1 to 7 exhibit, as described, good foam formation with small-pored foam which does not rapidly collapse, and stability. 10 The compositions according to the attached Examples 8 to 11 were prepared by the method given on page 20 of the present description. These Examples 8 to 11 are comparative products according to the prior art. As for Examples 1 to 7, 15 their behavior upon exiting from an aerosol device containing propellant gas was assessed. In each case a large-pored liquid foam was obtained (by visual observation) which rapidly collapsed. Examples 8 and 9 exhibit products with the polysiloxane emulsifier Abil® 20 Care 85 according to the invention, but without anionic or cationic surfactants, but with the nonionic surfactant tristeareth-4 phosphate (Hostaphat® KW 340 D) or steareth-21 (Brij 721) according to the prior art as described in the application page 5, paragraph 2 25 for Abil®. In Example 10, the nonionic surfactant present is Tween 80 and also the stabilizer is an acrylate-based polymer, namely Aristoflex AVCO as in EP - 30 B 0835 647 (prior art as described in the application on page 3, paragraph 2). In Example 11, the nonionic surfactant chosen is Tween 80. It is evident from this that, in contrast to the prior art, stable foam 5 compositions can surprisingly only be obtained if certain O/W-based polysiloxane emulsifiers are used which are then combined especially not with the coemulsifiers hitherto obligatory or else certain stabilizers. This was not expected since the prior art 10 teaches precisely the opposite, namely that such substances in particular should be obligatory for stable emulsions, particular when they are prepared hot.

Claims (18)

1. A composition based on an O/W emulsion, charac terized in that it has 2 to 50% of an oil phase, 5 0.1 to 10% of one or several silicone-based emulsifiers, 0.1 to 20% of one or several surfactants chosen from anionic and cationic surfactants, 0 to 40% of additives and water as the remainder. 10
2. The composition as claimed in claim 1, charac terized in that it is foamable.
3. The composition as claimed in claim 1 or 2, 15 characterized in that it has, as silicone-based emulsifier, one or several silicone-based O/W emulsifiers.
4. The composition as claimed in any of claims 1 to 20 3, characterized in that one or several anionic surfactants are present as surfactant(s).
5. The composition as claimed in any of claims 1 to 4, characterized in that one or several 25 polysiloxane-polyether copolymers are present as emulsifier(s).
6. The composition as claimed in claim 5, charac terized in that one or several polyethylene glycol 30 (PEG)-/polypropylene glycol (PPG)-polysiloxane copolymers having in each case 1-20 PEG, PPG units based on a polyether block in the ratio 1:0 to 0.9:1 are present as emulsifier. 35
7. The composition as claimed in claim 6, charac terized in that the polysiloxane-polyether copolymers are chosen from PEG/PPG-20/6 dimethi cones, bis-PEG/PPG-20/20 dimethicones, PEG-12 or - 32 PEG-14 dimethicones, PEG/PPG-14/4 or 14/12 or 14/14 or 20/20 or 18/18 or 17/18 or 15/15 dimethi cones or bis-PEG/PPG-16/16 PEG/PPG-16/16 dimethi cones or mixtures thereof. 5
8. The composition as claimed in any of claims 1 to 7, characterized in that one or several anionic surfactant(s) chosen from (alkyl) sarcosinates, alkyl sulfates, alkyl ether sulfates, (alkyl) 10 sulfosuccinates, (alkyl) sulfosuccinnamates, isethionates or mixtures thereof are present as surfactant.
9. The composition as claimed in claim 8, charac 15 terized in that one several sarcosinates, one or several sulfosuccinates, or mixtures thereof are present as anionic surfactant.
10. The composition as claimed in any of claims 1 to 20 9, characterized in that the emulsifier or the emulsifiers are present in a total amount of from 0.5 to 5% and the surfactant or the surfactants are present in a total amount of from 0.5 to 15%. 25
11. The composition as claimed in any of claims 1 to 10, characterized in that 1 to 30% of oil phase is present.
12. The composition as claimed in any of claims 1 to 30 11, characterized in that one or several substances chosen from hydrocarbons, fatty alcohols, fatty alcohol ethers, fatty acid esters, triglycerides, natural fats and oils, silicone oils and waxes are present as oil phase. 35
13. The composition as claimed in any of claims 1 to 12, characterized in that 0.01 to 25% of additives chosen from active ingredients, stabilizers, - 33 preservatives, dyes, perfume substances, consistency regulators, care substances, cosurfactants are present. 5
14. The composition as claimed. in claim 13, charac terized in that the additives are chosen from fatty alcohols, acrylate polymers, cosurfactants, cellulose derivatives, starch derivatives and/or humectants, conditioners. 10
15. The composition as claimed in any of claims 2 to 14, characterized in that it is in the form of a foam. 15
16. A method of producing a composition as claimed in any of claims 1 to 14, characterized in that the oil phase, the emulsifier or the emulsifiers, optionally together with thermally stable oil soluble additives are mixed and optionally heated 20 to 50 to 85 0 C and then the aqueous phase, optionally heated to 50 to 85*C and comprising water, the surfactant or the surfactants and optionally thermally stable additives are added with stirring, then, if necessary, the resulting 25 emulsion is cooled and, if present, thermally labile additives are added.
17. The use of a composition as claimed in any of claims 1 to 15 for the care, the cosmetic or 30 dermatological treatment or mild cleansing of normal, dry or dysfunctional skin.
18. The use of a composition as claimed in any of claims 1 to 15 for producing a composition for the 35 dermatological treatment of normal, dry or dysfunctional skin.
AU2003280389A 2002-10-31 2003-10-17 O/W emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use thereof Abandoned AU2003280389A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10250755A DE10250755B4 (en) 2002-10-31 2002-10-31 A foamable composition based on an O / W emulsion comprising a combination of a silicone-based emulsifier and an anionic surfactant having improved skin action, their preparation and their use
DE10250755.4 2002-10-31
PCT/EP2003/011528 WO2004039338A1 (en) 2002-10-31 2003-10-17 O/w emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use therof

Publications (1)

Publication Number Publication Date
AU2003280389A1 true AU2003280389A1 (en) 2004-05-25

Family

ID=32115019

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003280389A Abandoned AU2003280389A1 (en) 2002-10-31 2003-10-17 O/W emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use thereof

Country Status (5)

Country Link
EP (1) EP1555983B1 (en)
AT (1) ATE483498T1 (en)
AU (1) AU2003280389A1 (en)
DE (2) DE10250755B4 (en)
WO (1) WO2004039338A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10322269A1 (en) * 2003-05-16 2004-12-02 Clariant Gmbh Liquid detergents and cleaners with texturing polymers
US7695726B2 (en) 2004-01-23 2010-04-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Pigmented cosmetic composition exhibiting radiance with soft focus
WO2005070384A1 (en) * 2004-01-23 2005-08-04 Unilever Plc Taurate formulated pigmented cosmetic composition exhibitiing radiance with soft focus
DE102004016683A1 (en) * 2004-04-05 2005-10-27 Wella Ag Permanently foamed composition
DE102004057405A1 (en) * 2004-11-26 2006-06-01 Henkel Kgaa Oil-in-water emulsions
DE102004057406A1 (en) * 2004-11-26 2006-06-01 Henkel Kgaa Oil-in-water emulsions
DE102005038069A1 (en) * 2005-08-10 2007-03-08 Henkel Kgaa Oil-in-water emulsions
BRPI0503875A (en) * 2005-09-26 2007-06-12 Natura Cosmeticos Sa multifunctional cosmetic composition, process for preparing said cosmetic composition and cosmetic product
US20090035247A1 (en) * 2007-07-31 2009-02-05 Gabelnick Stephanie E Method of stabilizing a polysiloxane emulsion and compositions containing stabilized emulsions
DE102008042381A1 (en) * 2008-09-26 2010-04-01 Evonik Goldschmidt Gmbh Emulsifier systems for cosmetic and pharmaceutical oil-in-water emulsions
GB2470208B (en) * 2009-05-14 2014-01-29 Thornton & Ross Ltd A method and composition for the control of ectoparasites
DE102009028156A1 (en) 2009-07-31 2011-02-03 Evonik Stockhausen Gmbh Foamable O / W emulsion
DE102011018924A1 (en) 2011-04-28 2012-10-31 Tunap Industrie Chemie Gmbh & Co. Produktions Kg OW emulsion concentrate, process for its preparation and skin cosmetic containing it
US9198849B2 (en) 2013-07-03 2015-12-01 The Procter & Gamble Company Shampoo composition comprising low viscosity emulsified silicone polymers
JP2016533340A (en) 2013-09-27 2016-10-27 ザ プロクター アンド ギャンブル カンパニー Hair conditioning composition comprising low viscosity emulsifying silicone polymer
EP3273935A1 (en) 2015-03-24 2018-01-31 The Procter and Gamble Company Foam compositions, aerosol products, and methods of using the same to improve sensory benefits to the skin
EP3165216A1 (en) 2015-11-05 2017-05-10 Basf Se Textured composition
CN112675797B (en) * 2019-10-18 2022-07-12 中国石油化工股份有限公司 Alkaline washing tower, application thereof and method for dispersing butter in alkaline washing tower on line
WO2024000404A1 (en) * 2022-06-30 2024-01-04 L'oreal Composition for caring for and/or making up keratin materials

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227994A (en) * 1988-02-16 1990-09-26 Richardson Vicks Inc Skin conditioning composition comprising glycerin and a silicone fluid phase
US5169623A (en) * 1990-04-17 1992-12-08 Isp Investments Inc. Conditioning hair care compositions
WO1999008649A2 (en) * 1997-08-18 1999-02-25 Neubourg, Stephanie Foaming skin cream
US6071975A (en) * 1999-01-11 2000-06-06 Dow Corning Corporation Method of preparing silicone oil-in-water microemulsions
US6652867B1 (en) * 2000-09-25 2003-11-25 Dow Corning Corporation Compositions containing organic oil-in-water emulsions, salts, alcohols and solvents
DE10048683A1 (en) * 2000-09-30 2002-04-11 Beiersdorf Ag Preparation of water-based emulsion type W / O based on low-viscosity, well-spreading lipid components, further containing one or more alkyl methicone copolyols and / or alkyl dimethicopolyols
DE10059233B4 (en) * 2000-11-29 2009-08-13 CORONET Kleiderbügel & Logistik GmbH Mold for injection molding a clothes hanger
DE10059239A1 (en) * 2000-11-29 2002-06-06 Cognis Deutschland Gmbh Cosmetic and / or pharmaceutical emulsions
FR2827190A1 (en) * 2001-06-22 2003-01-17 Rhodia Chimie Sa USE OF AN OIL COMPRISING A POLAR GROUP AS AID FOR THE DEPOSITION OF NON-IONIZABLE POLAR OIL

Also Published As

Publication number Publication date
DE10250755B4 (en) 2007-02-08
EP1555983B1 (en) 2010-10-06
EP1555983A1 (en) 2005-07-27
ATE483498T1 (en) 2010-10-15
DE10250755A1 (en) 2004-05-19
WO2004039338A1 (en) 2004-05-13
DE50313164D1 (en) 2010-11-18
WO2004039338A8 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
AU2003280389A1 (en) O/W emulsion with a combination of a silicone-based emulsifier and one or several surfactants, selected from anionic and cationic surfactants, the production and use thereof
US8758734B2 (en) Sun protecting emulsion provided with a foam dispenser
US6375959B1 (en) Thickening homopolymer, preparation process and cosmetic applications
EP1443896B1 (en) Cosmetic preparation containing polycarbonates
EP2601166B1 (en) Cosmetic preparations
US20190083559A1 (en) Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue
US20080152604A1 (en) Skin-lightening compositions with an improved action
US20120128601A1 (en) Alkyl Sulfosuccinate Mixtures, And Use Thereof
US8148561B2 (en) Cosmetic oil substances
EP2448550B1 (en) Ester mixtures and compositions comprising such ester mixtures
EP2448551B1 (en) Ester mixtures and compositions comprising such ester mixtures
KR20080034182A (en) Use of polyisobutenyl succinic anhydride-based block copolymers in cosmetic preparations
US20120094919A1 (en) Use of tripeptides
US20050079141A1 (en) Cosmetic and/or pharmaceutical sunscreen preparations
JP4116020B2 (en) Oil-in-water fine emulsion containing hydrophilic screening agent
US20090169588A1 (en) Compositions Containing Proteins for the Transfer/Recycling of Structurally Modified Lipids, and the Applications Thereof
US7138128B2 (en) Preparations of the W/O emulsion type with an increased water content, and comprising cationic polymers
US20100297044A1 (en) Emulsifier Mixture Containing Fatty Alcohols, Ethoxylated Fatty Alcohols and Oil or Wax Components
US20050106190A1 (en) Cosmetic and/or pharmaceutical emulsions
AT501699B1 (en) DISPOSABLE COMPOSITION BASED ON O / W EMULSION, THEIR PRODUCTION AND THEIR USE
JP7165733B2 (en) Novel glyceryl polyrhamnosides, processes for their preparation and cosmetic and/or pharmaceutical compositions containing them
JP7143415B2 (en) Novel polyol polyrhamnosides, processes for their preparation and cosmetic and/or pharmaceutical compositions containing them
WO2012139817A2 (en) Oil-in-water emulsions
EP2269567A1 (en) Ester mixtures and compositions comprising such ester mixtures
JP2007126375A (en) Cosmetic or quasi-drug composition

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period